Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream.
Vanaclocha
F
F
Daudén
E
E
Badía
X
X
Guillén
C
C
Conejo-Mir
J S
JS
Sainz de Los Terreros
M
M
Hamel
L
L
Llorens
M A
MA
D000634:Aminoquinolines / Q000191:economics* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000191:economics* / Q000601:surgery; D003362:Cost-Benefit Analysis / Q000191:economics; D006801:Humans; D000077271:Imiquimod; D015580:Mohs Surgery / Q000191:economics*; D012878:Skin Neoplasms / Q000188:drug therapy / Q000191:economics* / Q000601:surgery
D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod